Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements
NCT ID: NCT04040543
Last Updated: 2021-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2019-07-26
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin/Mineral Absorption From Two Different Supplements
NCT05336994
Development of a Total Nutrient Index
NCT03400436
The Body's Response to Food Intake in Trained, Older Adults
NCT00798668
Evaluation of Biomarkers for Predicting Macronutrient Intake
NCT06582381
Nutrient Bioavailability From Microalgae
NCT04567823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Daily
Daily supplementation with product containing markers
lipid-based nutrient supplement containing adherence markers
The supplement will be provided once daily for 10 days
Intermittent
Daily supplementation with either the product containing markers or the product not containing markers
lipid-based nutrient supplement containing or not containing adherence markers
The product containing adherence markers will be provided once daily every other day (5 days total); the product not containing adherence markers will be provided on the intervening days for a total of 10 days.
Control
Daily supplementation with product not containing markers
lipid-based nutrient supplement not containing adherence markers
The supplement will be provided once daily for 10 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lipid-based nutrient supplement containing adherence markers
The supplement will be provided once daily for 10 days
lipid-based nutrient supplement containing or not containing adherence markers
The product containing adherence markers will be provided once daily every other day (5 days total); the product not containing adherence markers will be provided on the intervening days for a total of 10 days.
lipid-based nutrient supplement not containing adherence markers
The supplement will be provided once daily for 10 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diagnosis of chronic disease
* Use of medication that can affect gastrointestinal mobility
* Consumption of more than 7 alcoholic drinks per week
* Smoking
* Unwillingness to refrain from consuming dietary sources of the marker compound(s) 3 days prior to, and during the 12 day urine collection period
* Unwillingness to adhere to the study protocol
* Peanut allergy
* Cow milk allergy
* Soy allergy
* Almond allergy
* Allergy to adherence markers
* Pregnancy
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bill and Melinda Gates Foundation
OTHER
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marjorie Haskell, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1410234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.